Skip to main content
Top
Published in: Rheumatology International 10/2020

01-10-2020 | Vasculitis | Observational Research

Clinical characteristics of patients with myalgia as the initial manifestation of small and medium-sized vasculitis: a retrospective study

Authors: Satoru Ushiyama, Yasuhiro Shimojima, Ken-ichi Ueno, Dai Kishida, Daigo Miyazaki, Yoshiki Sekijima

Published in: Rheumatology International | Issue 10/2020

Login to get access

Abstract

Myalgia is a common symptom in small and medium-sized systemic vasculitis, sometimes occurring as the initial or only clinical manifestation of vasculitis. This study investigated the clinical features and diagnostic process in patients presenting with myalgia as the initial symptom of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) or polyarteritis nodosa (PAN). We included 93 patients diagnosed with AAV or PAN by retrospectively reviewing their clinical records at the initial diagnosis. Clinical findings and diagnostic methods were assessed in patients with myalgia. Of 93 patients, myalgia was observed in 21 (22.6%) patients, with diagnostic classifications of microscopic polyangiitis (MPA) in 12 (52.4%), granulomatosis with polyangiitis in 2 (9.5%), eosinophilic granulomatosis with polyangiitis in 2 (9.5%), and PAN in 5 (23.8%). Myalgia was present in the lower extremities of all patients; more than 80% of patients had pain in the calf muscle. In 10 patients with myalgia, including 7 with MPA and 3 with PAN, muscle biopsy was performed because myalgia was the main symptom and no other impaired organs were suitable for biopsy. Consequently, 8 patients had necrotizing vasculitis, leading to MPA or PAN diagnosis, although muscle pathology was not evaluated in patients without myalgia. Muscle magnetic resonance imaging was useful in determining the biopsy site. Myalgia, especially in the lower limbs, may be an initial clinical sign of vasculitis, particularly in MPA or PAN patients. Moreover, the histological evidence of muscular vasculitis can contribute to a definite diagnosis especially in patients presenting with myalgia as an early symptom of AAV or PAN.
Appendix
Available only for authorised users
Literature
5.
go back to reference Garcia F, Pedrol E, Casademont J, Mellado B, Cordoba R, Cid M et al (1992) Polyarteritis nodosa confined to calf muscles. J Rheumatol 19:303–305PubMed Garcia F, Pedrol E, Casademont J, Mellado B, Cordoba R, Cid M et al (1992) Polyarteritis nodosa confined to calf muscles. J Rheumatol 19:303–305PubMed
6.
go back to reference Hall C, Mongey AB (2001) Unusual presentation of polyarteritis nodosa. J Rheumatol 28:871–873PubMed Hall C, Mongey AB (2001) Unusual presentation of polyarteritis nodosa. J Rheumatol 28:871–873PubMed
Metadata
Title
Clinical characteristics of patients with myalgia as the initial manifestation of small and medium-sized vasculitis: a retrospective study
Authors
Satoru Ushiyama
Yasuhiro Shimojima
Ken-ichi Ueno
Dai Kishida
Daigo Miyazaki
Yoshiki Sekijima
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 10/2020
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-020-04652-y

Other articles of this Issue 10/2020

Rheumatology International 10/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine